Shijiazhuang Asa Technology Co., Ltd.
Shijiazhuang Asa Technology Co., Ltd.
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
  • Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox
Botulinum toxin Xeomin 50u 100u BOCOUTRE botox

Botulinum toxin Xeomin 50u 100u BOCOUTRE botox

Quantity:

Your message must be between 20 to 2000 characters

Contact Now
Basic Info
Basic Info
Product Description
Product Description



Bocouture is a prescription-only medicine indicated for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows. Suitable for the treatment of glabellar frown lines, periorbital lines crow’s feet lines  and horizontal forehead lines in adult patients under 65 years.

Summary:

  • Prescription-only medicine

  • Toxin indicated for the temporary improvement of lines and wrinkles

  • Suitable for the forehead and periorbital areas

  • Free from complexing proteins

Xeomin® is a smart toxin with a double-filtered formula that removes unnecessary proteins, so you get only what’s needed for smoother frown lines, treatment after treatment.

STATE-OF-THE-ART MANUFACTURING PROCESS.

Xeomin® is made through a unique precision manufacturing process called XTRACT Technology™, that uses two filtration steps to isolate the therapeutic component of the molecule and removes the complexing/unnecessary proteins that don’t play an active role in treatment. Xeomin® is a double filtered neurotoxin. Head-to-head studies evaluating the relative risk of immunogenicity due to the presence or absence of complexing/unnecessary proteins have not been performed.






Send your message to this supplier

  • Mr. asa zhang

  • Enter between 20 to 4,000 characters.